During a live event, Andrew Brunner, MD, and participants discussed escalating therapy in luspatercept-refractory LR-MDS. For patients with lower-risk myelodysplastic syndromes (LR-MDS) and ...
The Oakland score offers the greatest discrimination and specificity for identifying patients with lower GI bleeding who can be safely discharged from the ED.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results